Significant improvements in six-minute walking distance were reported in the STELLAR Phase III Trial whose findings were unveiled during a Featured Clinical Research session on the final day of the March 4-6 American College of Cardiology Scientific Session, ACC23 Together with WCC. Researchers added a novel first-in-class medication in combination with background therapy in patients with pulmonary arterial hypertension (PAH), a severe, progressive condition that affects the heart and lungs.
Atrial Fibrillation and Catheter Ablation nejm.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nejm.org Daily Mail and Mail on Sunday newspapers.
Research Goes Red: Early Experience With a Participant-Centric Registry ahajournals.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ahajournals.org Daily Mail and Mail on Sunday newspapers.